We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Saliva Test Detects Alcohol Exposure

By LabMedica International staff writers
Posted on 25 Aug 2010
Print article
Image: The Saliva-Alcohol Alco-Screen test (photo courtesy Forensic Laboratories).
Image: The Saliva-Alcohol Alco-Screen test (photo courtesy Forensic Laboratories).
An innovative analytical test is capable of detecting Ethyl Sulfate (EtS) and Ethyl Glucuronide (EtG), produced by the body after alcohol exposure, in a simple saliva sample.

The Saliva-Alcohol Alco-Screen test is intended for use as a rapid, highly sensitive method to detect the presence of alcohol in saliva to provide an approximation of relative blood alcohol concentration, allowing for greater detection sensitivity than breath testing methods. The simple, one-step, two-minute test requires no instrumentation, calibration, or special training to be used effectively. For applications where a qualitative determination of blood alcohol concentration is required for forensic purposes, liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology is used for confirmation of the oral fluid test result.

Since the relationship between the amount of saliva alcohol and blood alcohol is 1:1, while with breath it is 0.000048:1, saliva serves as a more sensitive testing medium than breath. Another advantage of saliva analysis is ease of collection, since the sample is produced with direct observation that is not gender dependent (such as a urine test), and the oral fluid collector can be easily labeled and secured in a strict chain of custody procedures. Oral fluid samples also provide a good indication of recent drug use, as most drugs are present in the saliva for 2-4 days after use. The Saliva-Alcohol Alco-Screen test is a product of Forensic Laboratories (Denver, CO, USA).

"Our mass spectrometry division was one of the first to offer the quantitation of both EtG and EtS in urine,” said James Ruth, Ph.D., Forensic Laboratories' laboratory director. "Now we are the first to offer EtS in oral fluid.”

Both EtG and EtS are minor but important metabolites of alcohol, because they are more slowly eliminated from the body than alcohol itself and can thus be used to better document and detect alcohol. Both EtG and EtS have similar time spectra; one standard drink, in an average person, can be detectable for about 24 hours (using the lowest cutoffs of 100 ng/ml for EtG and 25 ng/ml for EtS), whereas urine alcohol will disappear following one drink within about 4 to 6 hours; after binge drinking EtG and/or EtS can be detected in urine for several days or more. However, while EtG is degraded in urine when certain bacteria are present (which can cause a false negative test), EtS has not been shown to be degraded by bacteria.

Related Links:

Forensic Laboratories


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.